Trispecific Antibodies Protect Against HIV

News   Sep 22, 2017 | Original story from the National Institute of Allergy and Infectious Diseases

 
Trispecific Antibodies Protect Against HIV

Credit: Sanofi

 
 
 

RELATED ARTICLES

BioGenes Establishes Scientific Advisory Board

News

BioGenes GmbH, specializing in ELISA development and production and a global leader in host cell protein (HCP) assay development, announces the establishment of a Scientific Advisory Board.

READ MORE

The Discovery of Typhoid Toxin's Sweet Tooth Could Lead to New Treatments

News

"Our study shows that the typhoid toxin targets both the immune system and central nervous system... This represents a new paradigm in the infectious agents' incursion of the host." The new study shows how the toxin exclusively damages selected cells at the organism level, specifically seeking cells that express particular sugars because of their binding abilities.

READ MORE

New Drug Successfully Treats Huntington Patients

News

The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its first human trial, and successfully lowered the level of the harmful huntingtin protein in the nervous system.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE